Ibuvit D3 Baby

Colecalciferol, the active ingredient in Ibuvit D3 Baby, is a Vitamin D analog presented as a supplement for oral use. It addresses vitamin D deficiency and supports bone mineralization in infants, helping maintain healthy calcium and phosphate levels.

GNH USA supplies Ibuvit D3 Baby as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality compliance with EU standards for pediatric nutrition products.

Ibuvit D3 Baby provides colecalciferol to address conditions related to vitamin D metabolism in infants.

- Vitamin D deficiency: restores adequate vitamin D levels to support normal growth. - Rickets prevention: supplies the nutrient needed to prevent bone‑softening disorders. - General bone health support: promotes calcium and phosphate absorption for healthy skeletal development.

Side effects are generally uncommon but may occur, especially with excessive dosing.

Common Side Effects: - Nausea or vomiting - Constipation or abdominal discomfort - Mild hypercalcemia (elevated blood calcium) - Loss of appetite - Irritability in infants

Serious or Rare Side Effects: - Severe hypercalcemia with symptoms such as lethargy, dehydration, or cardiac arrhythmia - Kidney stones or nephrocalcinosis - Allergic reactions including rash, swelling, or breathing difficulty - Unexplained weight loss or failure to thrive - Persistent vomiting or severe gastrointestinal distress

When using Ibuvit D3 Baby, consider the following safety measures.

- Dosage verification: ensure the prescribed dose matches the infant’s age and weight. - Monitoring: periodically check serum calcium and vitamin D levels, especially in high‑risk infants. - Pre‑existing conditions: use caution in infants with hypercalcemia, kidney disease, or granulomatous disorders. - Concomitant supplements: avoid simultaneous high‑dose calcium or vitamin A products without medical guidance. - Storage: Store below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Colecalciferol may interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Thiazide diuretics: can increase risk of hypercalcemia. - Digitalis glycosides: heightened calcium levels may enhance toxicity. - High‑dose calcium supplements: may cause excessive calcium accumulation.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., phenobarbital, phenytoin): may reduce vitamin D effectiveness. - Corticosteroids: can impair vitamin D metabolism. - Aluminum‑containing antacids: may decrease absorption of colecalciferol. - Cholestyramine or other bile‑acid sequestrants: may lower oral vitamin D bioavailability.